*001677575
*00520190107141058.0
*007ta
*008130430s2012    no#           000 0 eng
*00901211cam a2200361 c 4500
*015  $a1219099$2nbf
*019  $bl
*020  $a9788230820094$qh.
*035  $a(EXLNZ-47BIBSYS_NETWORK)991215181404702201
*035  $a(NO-LaBS)14078826(bibid)
*035  $a(NO-TrBIB)121518140
*035  $a121518140-47bibsys_network
*040  $aNO-OsNB$bnob$ekatreg
*042  $anorbibl
*044  $cno
*060 4$aQV 77.9
*08274$a616.8918$qNO-OsNB$25/nor
*1001 $aSkrede, Silje$d1979-$0(NO-TrBIB)12030294$_96459900
*24510$aDeveloping a rodent model for antipsychotic-induced metabolic adverse effects$cSilje Skrede
*260  $a[Bergen]$bUniversity of Bergen$c2012
*300  $a1 b. (flere pag.)$bill.
*500  $aDelvis opptrykk av artikler
*502  $aAvhandling (ph.d.) - Universitetet i Bergen, 2012
*650 2$aAntipsychotic Agents$xadverse effects$_23549700
*650 2$aAntipsychotic Agents$xmetabolism$_49401500
*650 2$aModels, Animal$_50805200
*650 2$aRodentia$_60051100
*7102 $aUniversitetet i Bergen$0(NO-TrBIB)90063607$4dgg$_10049500
*7760 $tDeveloping a rodent model for antipsychotic-induced metabolic adverse effects$w991308577694702201
*901  $a90
*913  $aNorbok$bNB
*917  $ad
*999  $aoai:nb.bibsys.no:991215181404702202$b2021-12-08T03:25:19Z$z991215181404702202
^